Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals von Struck, Julian P., Schnoor, Maike, Schulze, Andrea, Hupe, Marie C., Ozimek, Tomasz, Oppolzer, Immanuel A., Schnabel, Marco J., Burger, Maximilian, Darr, Christopher, Gruenwald, Viktor, Hadaschik, Boris, Weinke, Maximilian, Kuebler, Hubert, Klockenbusch, Jonas C., Grabbert, Markus T., Gratzke, Christian, Kramer, Mario W., Katalinic, Alexander, Merseburger, Axel S.

Volltext

Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy von Sathe, Anuja, Chalaud, Géraldine, Oppolzer, Immanuel, Wong, Kit Yeng, von Busch, Margarita, Schmid, Sebastian C, Tong, Zhichao, Retz, Margitta, Gschwend, Juergen E, Schulz, Wolfgang A, Nawroth, Roman

Volltext

Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors von Oppolzer, Immanuel Augustin, Riester, Josef, Büttner, Roland, Burger, Maximilian, Schnabel, Marco Julius

Volltext